Skip to content

Role of Homoeopathy in the Management of Premenstrual syndrome

Effectiveness of Individualized Homoeopathic Medicine in The Management of Premenstrual Syndrome in Women of Reproductive Age Group A Prospective, Single arm, Open Label Clinical Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094738
Enrollment
40
Registered
2025-09-15
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N943- Premenstrual tension syndrome

Interventions

Intervention1: Individualized Homoeopathic Medicine: Individualized homoeopathic medicine will be prescribed based on detailed case taking, totality of symptoms and repertorization using suitable soft

Sponsors

Nehru Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Women of Reproductive age Group 15 years to 49 years 2.Regular menstrual cycle for 21 to 35 days for at least 3 consecutive months 3.Confirmed Diagnosis of PMS Diagnosis confirmed using at least one of the following Premenstrual Symptoms Screening Tool with moderate to severe symptoms Or ACOG criteria 1 or more than 1 affective and 1 or more than 1 somatic symptom in the 5 days before menses, resolving within 4 days of onset, in at least 2 consecutive cycles 4.History of Premenstrual symptoms for at least 3 months 5. Willing and able to provide informed consent 6. Able to read and understand the language of the symptom scales used 7.No Current Hormonal Therapy

Exclusion criteria

Exclusion criteria: 1.Current Use of Hormonal or Psychotropic Medications 2.History of Clinical Depression, generalized anxiety, bipolar disorder, or other psychiatric illness. 3.Diagnosis of Premenstrual Dysphoric Disorder 4.Other known diagnosed Gynecological Disorders Presence of conditions like PCOS, endometriosis, uterine fibroids, or PID that may affect or mimic PMS symptoms. 5.Known or previously diagnosed cases of chronic systemic illnesses (such as thyroid disorders, diabetes mellitus, renal, cardiac, or hepatic diseases) based on medical history or current medication records will be excluded. 6.Currently pregnant, planning to conceive, or breastfeeding during the study period. 7.History of alcohol dependence, tobacco use, or drug abuse. 8.Participation in Other Clinical Trials. 9.Individuals with a self-reported immunocompromised state e.g., HIV, ongoing immunosuppressive therapy.

Design outcomes

Primary

MeasureTime frame
Premenstrual Symptoms Screening ToolTimepoint: PSST will be evaluated at baseline and at 6 months

Secondary

MeasureTime frame
Premenstrual Tension Syndrome Observer Rating ScaleTimepoint: At baseline and at 6 months

Countries

India

Contacts

Public ContactDr Alka Meena

Nehru Homoeopathic Medical College and Hospital

drannpurna.sarngi@gmail.com9868396627

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026